Document
IPR2024-00201, No. 2 Motion Joinder - Petitioners Motion for Joinder (P.T.A.B. Nov. 20, 2023)
Cite Document
IPR2024-00201, No. 2 Motion Joinder - Petitioners Motion for Joinder (P.T.A.B. Nov. 20, 2023)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 350 (N.D.W.Va. Mar. 13, 2023)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 350 (N.D.W.Va. Mar. 13, 2023)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 262 (N.D.W.Va. Jan. 23, 2023)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 262 (N.D.W.Va. Jan. 23, 2023)
+ More Snippets
Document
IPR2022-01226, No. 16 Order on Motion - ORDER Granting Petitioners Motion for Admission Pro Hac Vice of Lauren M Lesko 37 CFR sec 4210 (P.T.A.B. Nov. 4, 2022)
Cite Document
IPR2022-01226, No. 16 Order on Motion - ORDER Granting Petitioners Motion for Admission Pro Hac Vice of Lauren M Lesko 37 CFR sec 4210 (P.T.A.B. Nov. 4, 2022)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 124 (N.D.W.Va. Nov. 29, 2022)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 124 (N.D.W.Va. Nov. 29, 2022)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 102 (N.D.W.Va. Nov. 17, 2022)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 102 (N.D.W.Va. Nov. 17, 2022)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 90 (N.D.W.Va. Nov. 2, 2022)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 90 (N.D.W.Va. Nov. 2, 2022)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 88 (N.D.W.Va. Oct. 28, 2022)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 88 (N.D.W.Va. Oct. 28, 2022)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 85 (N.D.W.Va. Oct. 20, 2022)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 85 (N.D.W.Va. Oct. 20, 2022)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 77 (N.D.W.Va. Sep. 29, 2022)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 77 (N.D.W.Va. Sep. 29, 2022)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 78 (N.D.W.Va. Sep. 29, 2022)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 78 (N.D.W.Va. Sep. 29, 2022)
+ More Snippets
Document
IPR2022-01226, No. 3 Notice Notice filing date accorded - Notice Notice filing date accorded (P.T.A.B. Jul. 13, 2022)
Cite Document
IPR2022-01226, No. 3 Notice Notice filing date accorded - Notice Notice filing date accorded (P.T.A.B. Jul. 13, 2022)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 74 (N.D.W.Va. Sep. 20, 2022)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 74 (N.D.W.Va. Sep. 20, 2022)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 26 (N.D.W.Va. Aug. 19, 2022)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 26 (N.D.W.Va. Aug. 19, 2022)
+ More Snippets
Document
IPR2022-01226, No. 94 Other other - Petitioners Brief in Response to the Boards Order Regarding the Construction of the Claim Term “Effective Sequential Dosing Regimen” (P.T.A.B. Nov. 3, 20...
Cite Document
IPR2022-01226, No. 94 Other other - Petitioners Brief in Response to the Boards Order Regarding the Construction of the Claim Term “Effective Sequential Dosing Regimen” (P.T.A.B. Nov. 3, 2023)
+ More Snippets